Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 8/20 | 1.00 |
| ▸ | CHRNA4 | P43681 | 8/20 | 1.00 |
| ▸ | CHRNA7 | P36544 | 5/20 | 1.00 |
| ▸ | CYP2A6 | P11509 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL229515 | 1.00 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| SCHEMBL26383447 | 1.00 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| SCHEMBL26181251 | 1.00 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| SCHEMBL11955257 | 1.00 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| SCHEMBL29634380 | 1.00 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| Hydrochloric Acid SCHEMBL29142854 | 0.98 | CHRNB2 (0.97) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| Anabasine SCHEMBL4725910 | 0.87 | CHRNB2 (0.76) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| Cadaverine Tartrate SCHEMBL229532 | 0.86 | CHRNB2 (0.74) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| Cadaverine Tartrate SCHEMBL229533 | 0.86 | CHRNB2 (0.74) | CHRNB2CHRNA4CHRNA7CYP2A6MEN1 | |
| Glutarate SCHEMBL21240777 | 0.85 | CHRNB2 (0.72) | CHRNB2CHRNA4CHRNA7CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2751 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630834-B2 | Methods and compositions for regulating alkaloids in tobacco | ALTRIA CLIENT SERVICES LLC (US) | 2026-05-19 | — | — | US | claimed |
| US-12624365-B2 | Method for modulating the alkaloid content of a tobacco plant | BRITISH AMERICAN TOBACCO (INVESTMENTS) LIMITED (GB) | 2026-05-12 | — | — | US | claimed |
| EP-4727345-A1 | TOBACCO PLANTS WITH REDUCED NICOTINIC ALKALOID LEVELS | North Carolina State University (US) | 2026-04-22 | — | — | EP | claimed |
| US-20260101860-A1 | TOBACCO PLANTS WITH REDUCED NICOTINIC ALKALOID LEVELS | UNIV NORTH CAROLINA STATE (US) | 2026-04-16 | — | — | US | claimed |
| US-12538922-B2 | Composition and methods for parasite control | PHILIP MORRIS PRODUCTS S.A. (CH) | 2026-02-03 | — | — | US | claimed |
| US-12527346-B2 | Pods for vaporizers and smoking products | CABBACIS LLC (US) | 2026-01-20 | — | — | US | claimed |
| EP-4676470-A2 | DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF | Ingenious Ingredients, LP (US) | 2026-01-14 | — | — | EP | claimed |
| EP-4654945-A1 | SYSTEM FOR ORAL DELIVERY OF AN ACTIVE INGREDIENT | Philip Morris Products S.A. (CH) | 2025-12-03 | — | — | EP | claimed |
| US-20250361222-A1 | Extraction of nicotine from tobacco by closed cycle steam stripping and scrubbing | SAMULIS LEOPOLD (GB) | 2025-11-27 | — | — | US | claimed |
| EP-4651705-A1 | METHOD | Nicoventures Trading Limited (GB) | 2025-11-26 | — | — | EP | claimed |
| US-20020025300-A1 | Edible herbal compositions for relieving nicotine craving | WOLFSON PHILIP (US) | 2002-02-28 | — | — | US | claimed |
| EP-1083913-A1 | MONOAMINE OXIDASE (MAO) INHIBITORS AND USES THEREOF | Regent Court Technologies (US) | 2001-03-21 | — | — | EP | claimed |
| CN-1272768-A | Method for treating tobacco to reduce nitrosamine content and products made thereby | REGENTCOURT TECHNOLOGY CO (US) | 2000-11-08 | — | — | CN | claimed |
| WO-1999062531-A1 | MONOAMINE OXIDASE (MAO) INHIBITORS AND USES THEREOF | REGENT COURT TECHNOLOGIES (US) | 1999-12-09 | — | — | WO | claimed |
| CN-1231583-A | Method for treating tobacco to reduce nitrosamine content and products produced thereby | WILLIAMS JONNIE R (US) | 1999-10-13 | — | — | CN | claimed |
| US-5705512-A | COGNITION ACTIVATORS USING PYRROLIDINE PYRIDINE | SIBIA NEUROSCIENCES, INC. (US) | 1998-01-06 | — | — | US | claimed |
| EP-0567251-B1 | Treatment of neurodegenerative diseases | REYNOLDS TOBACCO CO R (US) | 1996-11-06 | — | — | EP | claimed |
| EP-0739342-A1 | PYRIDINE MODULATORS OF ACETYLCHOLINE RECEPTORS | SIBIA NEUROSCIENCES, INC. (US) | 1996-10-30 | — | — | EP | claimed |
| WO-1996015123-A1 | PYRIDINE MODULATORS OF ACETYLCHOLINE RECEPTORS | SIBIA NEUROSCIENCES, INC. (US) | 1996-05-23 | — | — | WO | claimed |
| EP-0567251-A1 | Treatment of neurodegenerative diseases | R.J. REYNOLDS TOBACCO COMPANY (US) | 1993-10-27 | — | — | EP | claimed |